WCM
GSK icon

Winthrop Capital Management’s GSK GSK Stock Holding History

Winthrop Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Hold
3,978
– – 0.05% 120
2026
Q1 		$220K Hold
3,978
– – 0.06% 118
2025
Q4 		$195K Buy
3,978
+107
+3% +$4.99K 0.05% 128
2025
Q3 		$167K Buy
+3,871
New +$151K 0.04% 124

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Winthrop Capital Management's GSK Position: Q2 2026 in Review

Winthrop Capital Management held its GSK (GSK) position steady in Q2 2026 at 3,978 shares worth $209K. The position accounts for 0.05% of the portfolio, ranked #120.

Winthrop Capital Management first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $220K in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Winthrop Capital Management held 3,978 shares of GSK worth $209K as of Q2 2026.
  • Winthrop Capital Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.05% of Winthrop Capital Management's portfolio in Q2 2026, its #120 holding.
  • Winthrop Capital Management first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Winthrop Capital Management's GSK position peaked at $220K in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.